The injection port is a key component of drug delivery devices that allows for repetitive and controlled administration of therapeutic agents into the body. Injection ports are widely used in biological therapies where they offer patients hassle-free and frequent administration of drugs as required by complex treatment protocols. The growing reliance on biological therapies, particularly large molecule drugs for chronic conditions, has been a major driver for the global injection port market. Injection ports enable outpatient care and improve patients’ quality of life by reducing trips to healthcare facilities. They are incorporated into drug delivery devices like infusion pumps, accessory kits of implantable ports, and parenteral delivery systems. Demand for advanced drug delivery modes has increased due to the shift to self-administered long-acting medications.
The global Injection Port Market is estimated to be valued at Us$ 1.57 Bn in 2024 and is expected to exhibit a CAGR Of 7.6% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the injection port market has been the launch of wearable and multifunctional injection port systems. These new generation systems integrate wireless connectivity functions to allow remote monitoring of drug delivery in addition to offering convenient access ports for drug administration. For instance, in 2021, Sensile Medical announced the development of a smart injection port system which continually monitors bodily parameters and communicates treatment status to patients and healthcare providers via a mobile app. Another prominent trend is the emergence of non-visible and implantable injection ports to enhance patient comfort. Major players are focusing on introducing smaller and low-profile port designs that remain subcutaneous yet provide long-term vascular access. This has boosted adoption across ambulatory infusion clinics. Continuous advancements in material development are also enabling longer implant longevity and improved biocompatibility of injection ports.
Threat of new entrants: Low barriers for new manufacturers to enter the market makes the threat of new entrants moderate.
Bargaining power of buyers: The presence of many established manufacturers provides buyer options while negotiating for better pricing and volume discounts, increasing their bargaining power.
Bargaining power of suppliers: The high dependency on a limited number of raw material suppliers makes suppliers command better margins and bargaining power.
Threat of new substitutes: Alternative delivery methods are being explored but injectable drugs remain popular, keeping the threat of substitutes low.
Competitive rivalry: The market is fragmented with many global and regional players competing on drug development and approvals.
The Global Injection Port Market Demand is expected to witness high growth. The global Injection Port Market is estimated to be valued at US$ 1.57 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031.
Regional analysis comprises the North American region dominates currently due to many key players located in the region and high healthcare spending. The Asia Pacific region is expected to witness fastest growth due to growing healthcare infrastructure and increasing generic drug production.
Key players operating in the Injection Port Market are Jungbunzlauer, Gellner Industrial, LLC, PolyOne Corporation, Röchling Group, RAUMEDIC AG.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it